-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Gregory Stuart Smith Purchases 3,500 Shares of ImmunoPrecise Antibodies Ltd (TSE:IPA) Stock
Gregory Stuart Smith Purchases 3,500 Shares of ImmunoPrecise Antibodies Ltd (TSE:IPA) Stock
ImmunoPrecise Antibodies Ltd (TSE:IPA – Get Rating) Director Gregory Stuart Smith purchased 3,500 shares of ImmunoPrecise Antibodies stock in a transaction dated Friday, September 23rd. The stock was bought at an average price of C$5.41 per share, with a total value of C$18,935.00. Following the acquisition, the director now directly owns 42,500 shares of the company's stock, valued at C$229,925.
Gregory Stuart Smith also recently made the following trade(s):
Get ImmunoPrecise Antibodies alerts:- On Monday, August 15th, Gregory Stuart Smith purchased 5,000 shares of ImmunoPrecise Antibodies stock. The stock was bought at an average price of C$6.93 per share, with a total value of C$34,670.00.
ImmunoPrecise Antibodies Price Performance
ImmunoPrecise Antibodies Company Profile
(Get Rating)
IPA is an innovation-driven, technology platform company that supports its pharmaceutical and biotechnology company partners in their quest to discover and develop novel, therapeutic antibodies against all classes of disease targets. The Company aims to transform the conventional, multi-vendor, product development model by bringing innovative and high-throughput, data-driven technologies to its partners, incorporating the advantages of diverse antibody repertoires with the Company's therapeutic antibody discovery suite of technologies, to exploit antibodies of broad epitope coverage, multiple antibody formats, valency and size, and to discover antibodies against multiple/rare epitopes.Featured Articles
- Why Does Tesla Stock Remain Resilient?
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- 2 Semiconductor Stocks To Watch For Reversals
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
ImmunoPrecise Antibodies Ltd (TSE:IPA – Get Rating) Director Gregory Stuart Smith purchased 3,500 shares of ImmunoPrecise Antibodies stock in a transaction dated Friday, September 23rd. The stock was bought at an average price of C$5.41 per share, with a total value of C$18,935.00. Following the acquisition, the director now directly owns 42,500 shares of the company's stock, valued at C$229,925.
免疫精制抗体有限公司(东京证券交易所代码：IPA-GET评级)董事格雷戈里·斯图尔特·史密斯在一笔日期为9月23日(星期五)的交易中购买了3,500股免疫精制抗体股票。该股是以每股5.41加元的平均价格购买的，总价值为18,935.00加元。收购完成后，董事现在直接拥有该公司42,500股股票，价值229,925加元。
Gregory Stuart Smith also recently made the following trade(s):
格雷戈里·斯图尔特·史密斯最近还进行了以下交易：
- On Monday, August 15th, Gregory Stuart Smith purchased 5,000 shares of ImmunoPrecise Antibodies stock. The stock was bought at an average price of C$6.93 per share, with a total value of C$34,670.00.
- 8月15日，星期一，格雷戈里·斯图尔特·史密斯购买了5,000股免疫精抗体股票。该股是以每股6.93加元的平均价格购买的，总价值为34,670.00加元。
ImmunoPrecise Antibodies Price Performance
免疫精确型抗体的性价比
ImmunoPrecise Antibodies Company Profile
免疫精准抗体公司简介
(Get Rating)
(获取评级)
Featured Articles
专题文章
- Why Does Tesla Stock Remain Resilient?
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- 2 Semiconductor Stocks To Watch For Reversals
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- 为什么特斯拉的股票保持弹性？
- CrowdStrike是否会从增加每股收益指引中获得提振？
- 好市多盈利后价格疲软是买入的好时机吗？
- 需要关注的2只半导体类股走势逆转
- 小盘股的裁员是楼市的晴雨表吗？
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
每天收到关于免疫精准抗体的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯，接收最新新闻和分析师对免疫精准抗体和相关公司的评级的每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧